Megan Baldwin, PhD
CEO & Managing Director
Dr Megan Baldwin is CEO/Managing Director of Opthea Limited and has over 19 years of experience in preclinical and clinical development of therapies for cancer and eye diseases. Dr Baldwin joined Opthea in 2008 and since then has held various positions. Prior to joining Opthea, Dr Baldwin was employed at Genentech (now Roche) in San Francisco, USA. Her experience included several years as a post-doctoral researcher in the group of leading investigator Prof. Napoleone Ferrara, before moving to Genentech’s commercial division and having responsibility for competitive intelligence activities. Dr Baldwin holds a PhD in medicine from the University of Melbourne, having conducted her doctoral studies at the Ludwig Institute for Cancer Research and is a member of the Australian Institute for Company Directors.